Hospital
Bullhead City Hospital Corporation
Bullhead City Hospital Corporation was paid $28.54M by Medicaid between Jan 2018 and Dec 2024, across 209 billing codes. Its largest line is 99284, emergency room visit (serious) — 18% of everything it billed.
33Billing provider infoBULLHEAD CITY HOSPITAL CORPORATION
BULLHEAD CITY, AZ 86442
BULLHEAD CITY, AZ 86442
33aNPI1255302766assigned 02/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.54M
24GClaims607,694
24DCodes billed209
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Arizona
Rank by total paid#18 of 78
Median peer was paid$12.21M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 108,700 | $4.42M | |
| 2019 | 107,475 | $4.94M | |
| 2020 | 90,712 | $4.17M | |
| 2021 | 82,946 | $4.06M | |
| 2022 | 79,008 | $3.96M | |
| 2023 | 83,961 | $4.15M | |
| 2024incomplete | 54,892 | $2.83M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 24,009 | 21,204 | $5.27M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 29,474 | 26,680 | $4.86M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 12% | 5,818 | 5,296 | $3.30M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 11,197 | 9,462 | $2.59M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.3% | 4,114 | 3,778 | $1.78M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.3% | 10,997 | 10,370 | $1.24M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.0% | 4,603 | 1,948 | $1.13M |
| 70450 | Computed tomography, head or brain; without contrast material | 3.7% | 5,349 | 4,842 | $1.06M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.3% | 10,172 | 2,950 | $931K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.5% | 11,351 | 10,556 | $720K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.3% | 6,409 | 2,097 | $662K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 21,140 | 17,510 | $644K |
197 more codes
| 72125 | Computed tomography, cervical spine; without contrast material | 1.7% | 1,671 | $476K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.5% | 2,567 | $427K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.2% | 769 | $337K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,365 | $283K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,933 | $276K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 12,933 | $265K |
| 72100 | <1% | 3,366 | $213K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 438 | $210K |
| 93971 | <1% | 598 | $105K | |
| 80053 | Comprehensive metabolic panel | <1% | 36,063 | $99K |
| 74021 | <1% | 1,159 | $89K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,261 | $70K |
| 73562 | <1% | 2,438 | $66K | |
| 0450 | Emergency room services | <1% | 1,702 | $63K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 651 | $60K |
| 73030 | <1% | 2,460 | $60K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,344 | $58K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,731 | $55K |
| 71250 | <1% | 696 | $54K | |
| 97161 | <1% | 354 | $52K | |
| 76830 | Ultrasound, transvaginal | <1% | 726 | $50K |
| G0378 | Hospital observation service, per hour | <1% | 1,451 | $49K |
| 71045 | Radiologic examination, chest; single view | <1% | 17,606 | $47K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 13,868 | $44K |
| 76641 | <1% | 336 | $42K | |
| 86756 | <1% | 890 | $38K | |
| 72040 | <1% | 1,708 | $37K | |
| 73630 | <1% | 2,357 | $36K | |
| 73130 | <1% | 2,034 | $35K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,374 | $35K |
| 97597 | <1% | 348 | $34K | |
| 73610 | <1% | 1,672 | $30K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 4,052 | $30K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 102 | $27K |
| 74018 | <1% | 910 | $26K | |
| 70486 | <1% | 154 | $23K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,343 | $22K |
| 73110 | <1% | 921 | $21K | |
| 73502 | <1% | 842 | $17K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 238 | $17K |
| 72072 | <1% | 155 | $17K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,980 | $17K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 492 | $16K |
| 73560 | <1% | 163 | $16K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,935 | $16K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 334 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,733 | $15K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 61 | $11K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 5,980 | $11K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 799 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,001 | $10K |
| 83880 | <1% | 7,555 | $10K | |
| 72110 | <1% | 59 | $9K | |
| 84484 | <1% | 15,776 | $9K | |
| 86850 | <1% | 971 | $9K | |
| 81001 | <1% | 23,665 | $9K | |
| 83690 | <1% | 12,942 | $9K | |
| 87186 | <1% | 2,275 | $7K | |
| 76536 | <1% | 129 | $7K | |
| 83735 | <1% | 14,405 | $6K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,042 | $5K |
| 85730 | <1% | 11,151 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,249 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 771 | $5K |
| Z7502 | <1% | 116 | $4K | |
| 97162 | <1% | 31 | $4K | |
| 73522 | <1% | 29 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 302 | $4K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $3K |
| 73120 | <1% | 40 | $3K | |
| 85610 | <1% | 13,026 | $3K | |
| 81025 | <1% | 4,612 | $3K | |
| 87088 | <1% | 5,992 | $3K | |
| 72131 | <1% | 26 | $3K | |
| 80050 | General health panel | <1% | 44 | $3K |
| 93880 | <1% | 58 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,505 | $3K |
| 93970 | <1% | 27 | $3K | |
| 93017 | <1% | 44 | $3K | |
| 76775 | <1% | 48 | $2K | |
| 72114 | <1% | 12 | $2K | |
| 83605 | <1% | 4,371 | $2K | |
| 72070 | <1% | 70 | $2K | |
| 10060 | <1% | 61 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,486 | $2K |
| 87040 | <1% | 4,694 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,214 | $2K |
| 87070 | <1% | 305 | $2K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 960 | $2K |
| 96376 | <1% | 1,110 | $2K | |
| 82550 | <1% | 3,794 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,357 | $2K |
| 76870 | <1% | 13 | $2K | |
| 82150 | <1% | 1,824 | $2K | |
| 29581 | <1% | 62 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 21 | $2K |
| 71101 | <1% | 64 | $2K | |
| 84703 | <1% | 2,822 | $1K | |
| 87430 | <1% | 1,988 | $1K | |
| 82553 | <1% | 2,020 | $1K | |
| 73080 | <1% | 95 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,699 | $1K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 2,528 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 5,057 | $944.85 |
| 73590 | <1% | 70 | $834.88 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,763 | $817.91 |
| 84145 | <1% | 1,214 | $713.36 | |
| 76770 | <1% | 13 | $703.68 | |
| 90715 | <1% | 520 | $585.54 | |
| 84100 | <1% | 2,791 | $579.18 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,970 | $573.66 |
| 82962 | <1% | 5,376 | $561.63 | |
| 77080 | <1% | 17 | $538.21 | |
| 87490 | <1% | 341 | $529.92 | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,140 | $488.34 |
| 12001 | <1% | 17 | $473.11 | |
| 84702 | <1% | 472 | $460.23 | |
| 87590 | <1% | 341 | $459.42 | |
| 73620 | <1% | 13 | $453.92 | |
| 84436 | <1% | 1,258 | $450.01 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,320 | $443.74 |
| J3490 | Unclassified drugs | <1% | 89 | $397.99 |
| 86901 | <1% | 1,706 | $393.60 | |
| 85027 | <1% | 1,262 | $390.85 | |
| 86140 | <1% | 1,428 | $337.49 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,956 | $335.42 |
| 86900 | <1% | 1,707 | $288.79 | |
| 94644 | <1% | 223 | $276.35 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,010 | $268.16 |
| 73090 | <1% | 25 | $267.62 | |
| 73070 | <1% | 13 | $258.70 | |
| 85014 | <1% | 52 | $257.37 | |
| 51702 | <1% | 77 | $250.46 | |
| 80076 | <1% | 489 | $248.30 | |
| 96367 | <1% | 168 | $225.59 | |
| 80061 | Lipid panel | <1% | 973 | $223.24 |
| 93922 | <1% | 28 | $219.72 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,548 | $216.14 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 972 | $209.75 |
| 82803 | <1% | 41 | $130.35 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,803 | $128.95 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,464 | $121.52 |
| 82140 | <1% | 257 | $117.97 | |
| 72050 | <1% | 15 | $110.81 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,453 | $107.63 |
| 85379 | <1% | 306 | $107.21 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,027 | $100.48 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,879 | $97.50 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,637 | $95.13 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 39 | $88.62 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 337 | $84.19 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 469 | $83.65 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 783 | $81.69 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 150 | $67.15 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,617 | $66.95 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 875 | $56.51 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 241 | $54.26 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,069 | $51.55 |
| 76000 | <1% | 28 | $40.11 | |
| 85652 | <1% | 354 | $37.97 | |
| 82728 | <1% | 170 | $34.66 | |
| 94760 | <1% | 49 | $30.51 | |
| 36600 | <1% | 35 | $18.16 | |
| 87075 | <1% | 61 | $17.86 | |
| 83615 | <1% | 98 | $16.27 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 171 | $15.20 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 126 | $13.41 |
| 83655 | <1% | 24 | $12.68 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 590 | $7.95 |
| 84439 | <1% | 58 | $7.91 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 90 | $5.71 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 117 | $1.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 82 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 13 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 18 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 102 | $0.00 |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 23 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 183 | $0.00 |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 0% | 69 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 65 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 37 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 21 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 29 | $0.00 |
| 88312 | 0% | 12 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 64 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 1,066 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 0% | 32 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 387 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 15 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 254 | $0.00 |
| 11045 | 0% | 25 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 48 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 13 | $0.00 |
| C1769 | Guide wire | 0% | 59 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 17 | $0.00 |
| 76801 | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.